Delaware court enters USD 4 million judgment for Biohaven, Yale in trade secret case against RA Capital, Avilar
Reuters2026/08/26 09:52- Federal judge in Delaware entered judgment confirming a jury verdict against RA Capital Management, Avilar Therapeutics in a trade secret case tied to Yale’s MODA platform.
- Judgment formalized a combined USD 4 million award to Yale, Biohaven for willful, malicious misappropriation of the trade secret.
- RA Capital also found to have breached a 2019 confidentiality agreement with Yale, driving USD 2 million of the total award.
- Case stems from talks that ended in August 2019, followed by allegations RA Capital used shared technical information to build a competing program.
- Post-trial motions remain possible, leaving the final outcome subject to further court review.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Why hasn’t the rise in US Treasury yields boosted the US dollar exchange rate?
Gurman predicts iPhone Duo: The first foldable may set industry standards, Apple (AAPL.US) foldable could trigger a decade-long upgrade cycle
Renowned financial journalist Mark Gurman stated that Apple’s first foldable iPhone has the potential to elevate the still-experimental foldable phone category to an industry standard. He noted that this device, called the iPhone Duo, is one of Apple’s most influential products, ranking just behind the iMac, iPod, iPad, and Apple Watch.
Element Fleet drops bid for FleetPartners, exits sale process
Anchoring to Nasdaq! Anthropic races toward a record-breaking IPO with fundraising scale targeting SpaceX
Sources indicate that Anthropic PBC has chosen Nasdaq as its listing venue, and the potential IPO is expected to set a historic record.
Crypto prices
More
